Your email has been successfully added to our mailing list.

×
0 0 0 0 0 -0.00416666666666661 0.0183641975308644 0.00802469135802485
Stock impact report

Study Shows Guardant360 Test Identifies Predictors of Response to PIK3CA Inhibitors in Women with HR+ Metastatic Breast Cancer

Guardant Health, Inc. (GH) 
Last guardant health, inc. earnings: 2/24 04:03 pm Check Earnings Report
Company Research Source: GlobeNewswire
REDWOOD CITY, Calif., April 09, 2020 (GLOBE NEWSWIRE) -- Many women with metastatic hormone receptor-positive (HR+) breast cancer have experienced improved clinical outcomes with the recent introduction of alpelisib, a PIK3CA inhibitor. A new study led by Memorial Sloan Kettering Cancer Center and published in Nature Cancer1 demonstrates that the Guardant360® liquid biopsy test effectively identified patients with PIK3CA mutations along with other mutations that correlate with treatment resistance. The phase I/II study (NCT01870505), a longitudinal analysis of tumor and blood-based circulating tumor DNA (ctDNA) in metastatic patients treated with alpelisib plus fulvestrant showed 89 percent concordance between tissue and blood for PIK3CA mutations. In the study, the Guardant360 liquid biopsy test also detected significantly more potential resistance alterations compared to tissue biopsy testing. These findings build upon the plasmaMATCH study results2 showing the importance of us Show less Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for GH alerts
Opt-in for
GH alerts

from News Quantified
Opt-in for
GH alerts

from News Quantified